Concepedia

Hiroko Bando

HB

Statistics

Publications

62

Citations

3.6K

H-Index

32

Active since

2000

Affiliations

University of Tsukuba(Current)

Tokyo Metropolitan Komagome Hospital

Kyoto University

University of Tsukuba Hospital

Aichi Cancer Center

Hiroko Bando is an author at University of Tsukuba specializing in oncology, medicine, and breast oncology.

ORCID

Publications per year

2000–2025

62

Publications

62

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Takayuki Ueno, Masakazu Toi, Hisashi Saji et al. · PubMed · 2000 · 711 citations

, , +17

Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo

Masakazu Toi, Hiroko Bando, Cheppail Ramachandran et al. · Angiogenesis · 2003 · 147 citations

, , +10

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor‐1 relationship in breast cancer

Masakazu Toi, Hiroko Bando, T Ogawa et al. · International Journal of Cancer · 2001 · 130 citations

, , +16

Measurement of an apoptotic product in the sera of breast cancer patients

Takayuki Ueno, Masakazu Toi, Kenneth Bivén et al. · European Journal of Cancer · 2003 · 127 citations

, , +9

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

, , +13

1–5 of 62